Cosmo I Building Health Confidence

Cosmo is a healthcare company focused on helping people live and work with confidence through science, technology, and innovation. Its work spans MedTech AI, dermatology, gastroenterology, and contract development and manufacturing (CDMO). The company aims to support patients, healthcare professionals, and partners with solutions that address both the physical and emotional effects of health conditions.

Cosmo’s therapeutic focus includes inflammatory bowel disease, colonic infections, colorectal cancer, acne, and androgenetic alopecia. Across these areas, it combines scientific expertise and technology to advance research and therapeutic innovation. Its work also includes AI-enabled healthcare and contract manufacturing capabilities, bringing together teams across its divisions to develop and deliver solutions.

The company reports clinical progress in gastroenterology, including a positive Phase 2 study of a topically acting rifamycin 1% gel. The study met its primary endpoint in distal ulcerative colitis and ulcerative proctitis. Through its focus on persistent health challenges and collaboration with healthcare professionals and partners, Cosmo seeks to improve care and help people take greater control of their gut, skin, and hair health.